Search

Your search keyword '"Donisi, Alessandra"' showing total 2 results
Start Over Author "Donisi, Alessandra" Database OpenAIRE
2 results on '"Donisi, Alessandra"'

1. Treatment for COVID-19—a cohort study from Northern Italy

Author

Guglielmetti, Lorenzo, Aschieri, Daniela, Kontsevaya, Irina, Calabrese, Francesco, Donisi, Alessandra, Faggi, Alberto, Ferrante, Patrizia, Fronti, Elisa, Gerna, Laura, Leoni, Maria Cristina, Paolillo, Franco, Ratti, Giovanna, Ruggieri, Alessandro, Sacchini, Daria, Scotti, Marta, Valdatta, Caterina, Stabile, Marco, Taliani, Gloria, Codeluppi, Mauro, Centre d'Immunologie et des Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Piacenza Hospital, Centre National de Référence des Mycobactéries et de la Résistance aux Antituberculeux [CHU Pitié-Salpêtrière] (CNR-MyRMA), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Forschungszentrum Borstel - Research Center Borstel, Lübeck University of Applied Sciences, Campus Universitat Illes Balears, Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA), HAL-SU, Gestionnaire, Centre d'Immunologie et de Maladies Infectieuses (CIMI), Centre National de Référence des Mycobactéries et de la Résistance aux Antituberculeux [CHU Pitié-Salpêtrière], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], and Società Italiana di Malattie Infettive e Tropicali

Subjects
Male, Epidemiology, Science, Azithromycin, Antibodies, Monoclonal, Humanized, Antiviral Agents, Article, Patient Admission, Adrenal Cortex Hormones, Humans, Hospital Mortality, Aged, Probability, Proportional Hazards Models, Retrospective Studies, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Heparin, SARS-CoV-2, COVID-19, Middle Aged, COVID-19 Drug Treatment, Hospitalization, Treatment Outcome, Italy, Viral infection, Medicine, Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

Multicentre, retrospective cohort study with multivariable Cox proportional-hazards modelling and survival-time inverse-probability-weighting, evaluating the impact of different treatments on survival of proven COVID-19 patients admitted to two Hospitals in the province of Piacenza, Italy. Use of tocilizumab and of high doses of low molecular weight heparin, but not of antivirals (either alone or in combination), azithromycin, and any corticosteroid, was independently associated with lower mortality. Our results support further clinical evaluation of high doses of low molecular weight heparin and tocilizumab as COVID-19 therapeutics., The work of the corresponding author (LG) in the Hospital of Piacenza was supported by the Italian Society of Infectious and Tropical Diseases (SIMIT).

Published
2021

2. Screening approach among newly arrived asylum seekers: experience in a primary health care setting in Piacenza, Emilia Romagna, Northern Italy

Author

DONISI, ALESSANDRA, GERNA, LAURA, FIETTA, TOMMASO, and GRECCHI, CECILIA

Subjects
Adult, Male, Refugees, 0303 health sciences, Primary Health Care, 030306 microbiology, virus diseases, HIV Infections, Hepatitis B, Migrants, Hepatitis C, 03 medical and health sciences, Italy, Screening, Infectious diseases, Humans, Mass Screening, Tuberculosis, Original Article, Female, Syphilis
Abstract

In the last ten years the number of asylum seekers has increased in all of Europe. Our Migrants Health Unit in Piacenza, Emilia Romagna, Italy, is designated to provide primary health care for migrants without a regular permit of stay and, since 2015, is the reference center for asylum-seekers in our Province. Aim of this study is to describe the results of the screening for infectious diseases performed in asylum seekers from January 2015 to December 2015. For any asylum seekers referred to our Centre, we recorded demographical data and we offered screening for HIV, HBV, HCV, syphilis and active tuberculosis (TB). Descriptive statistics were used to analyze the characteristics of the cohort. In 2015, 316 asylum seekers accessed to our Centre. Of them, the majority were men (N= 275; 87,03%). Africa was the most represented geographical area (221, 69,94%), followed from Asia (95, 30.06%). The median age was 25,4 years. 301 patients underwent chest X-Ray, that resulted negative in 262 cases (87%). HBsAg testing proved to be positive in 17 (5,3%) cases. The screening test for HBV, HCV, HIV and syphilis resulted respectively positive in 5.3%, 1.9%, 0.3% and 1.6%., Journal of Preventive Medicine and Hygiene, Vol. 61 No. 3 (2020): 2020613

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results